FDA panel: Concentric's thrombectomy device needs more trials
This article was originally published in Clinica
Executive Summary
An FDA advisory panel told the agency this week that Concentric Medical should conduct a clinical trial before its thrombectomy device is cleared for marketing as an alternative way of treating a cerebrovascular stroke.